Non-Hodgkin-Lymphome

  • U. Göbel
  • H. Jürgens
Chapter

Zusammenfassung

Bei den Non-Hodgkin-Lymphomen ist neben dem Tumorstadium die Zuordnung zu einer der 4 Subgruppen

  • Burkitt- und Burkitt-ähnliche Lymphome

  • großzellige B-Zell-Lymphome

  • lymphoblastische Lymphome

  • anaplastisch-großzellige Lymphome

von prognostischer Bedeutung. Durch eine stadienabhängigeTherapie können heute hohe Heilungsraten durch eine intensive Polychemotherapie erzielt werden, so dass auf die früher eingesetzte Strahlentherapie weitgehend verzichtet werden kann. Operative Maßnahmen dienen der Diagnostik (Biopsie), der Resektion eng begrenzter Primärherde und der Erfolgsbeurteilung (»second look operation«) mit Entfernung postchemotherapeutischer Residuen.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Cairo MS, Perkins S (2000) Non-Hodgkin’s lymphoma in children. In: Bast RC Jr, Kufe DW, Polock RE et al. (eds) Cancer medicine, 5th edn. Decker, London, pp 2162–2167Google Scholar
  2. Harris NL, Stein H, Coupland SE et al. (2001) New approaches to lymphoma diagnosis. Hematology (Am Soc Hematol Educ Program): 194–220Google Scholar
  3. Kobrinsky NL, Sposto R, Shah NR et al. (2001) Outcomes of treatment of children and adolescents with recurrent non-Hodgkin’s lymphoma and Hodgkin’s disease with dexamethasone, etoposide, cisplatin, cytarabine, and I-aspraginase, maintenance chemotherapy, and transplantation. Children’s Cancer Group Study CCG-5912.) Clin Oncol 19: 2390–2396Google Scholar
  4. Lones MA, Cairo MS, Perkins SL (2000) T-cell-rich large V-cell lymphoma in children and adolescents:a clinicopathologic report of six cases from the Childrens’s Cancer Group Study CCG-5961. Cancer 88: 2378–2386PubMedCrossRefGoogle Scholar
  5. Pagnano JS (2002) Viruses and lymphomas. N Engl J Med 347 /2: 78–79CrossRefGoogle Scholar
  6. Patte C, Auperin A, Michon J et al. (2001) The Societé Francaise d’Oncologie Pédiatrique LMB-89-Protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood 97: 3370–3379PubMedCrossRefGoogle Scholar
  7. Reiter A, Schrappe M, Tiemann et al. (1999) Improved treatment results in childhood B-Cell neoplasms with tailored intensification of therapy: a report of the Berlin-Frankfurt-Münster Group Trail NHL-BFM 90. Blood 94: 3294–3306PubMedGoogle Scholar
  8. Sposto R, Meadows AT, Chilcote RR et al. (2001) Comparison of longterm outcome of children and adolescents with desseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: a report from the Children’s cancer Group. Med Pediatr Oncol 37: 432–441PubMedCrossRefGoogle Scholar
  9. Staudt LM (2001) Genomic-scale gene expression profiling of lymphoid malignancies reveals new cancer types. Proc Am Soc Clin Oncol 19: 252–255Google Scholar
  10. Wagner H-J, Fischer L, Jabs W et al. (2002) Longitudinal analysis of Epstein-Barr viral load in plasma and peripheral blood mononuclear cells of transplanted patients by real-time Polymerase chain reaction.Transplantation 73: 656–664Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • U. Göbel
  • H. Jürgens

There are no affiliations available

Personalised recommendations